Drug intelligence / Profile preview

Affibody-Chiesi respiratory program

Development stage
Preclinical
Lead developer
Chiesi
Modality
Peptides, Recombinant Proteins and Enzymes
Administration
Inhalation
01

Overview

The Affibody-Chiesi respiratory program is a collaborative research and development initiative between Affibody and Chiesi Farmaceutici focused on creating novel treatments for respiratory diseases. The program utilizes Affibody's proprietary protein platform to develop Affibody® molecules—small, robust engineered scaffold proteins (approximately 6 kDa) designed to bind with high affinity and selectivity to specific biological targets. These molecules are being developed for delivery via inhalation, leveraging Chiesi's specialized expertise in respiratory medicine and inhalation technology. As of early 2024, the specific molecular targets, mechanism of action, and lead candidate code names remain undisclosed by the partners.

Other names
Chiesi/Affibody respiratory program

Beyond the preview

Go deeper on Affibody-Chiesi respiratory program.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Affibody-Chiesi respiratory program.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call